1. 1Dana-Farber Cancer Institute, Boston, Massachusetts.
2. 2Harvard Medical School, Boston, Massachusetts.
3. 3Division of New Drugs and Early Drug Development, European Institute of Oncology, IRCCS, Milan, Italy.
4. 4Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.